<p>For patients with opioid use disorder taking buprenorphine-naloxone, it is deemed appropriate to continue three times-daily dosing</p>
<p>Nine in 10 oncologists believe this mental health distress impacts health outcomes</p>
<p>Risk highest in the first year after diagnosis, but remains higher in those living in the lowest-income counties </p>
<p>Suicide risk significantly elevated for survivors alive beyond the age of 28 years; risk was lower for women than men</p>
<p>Factors associated with use or nonuse found to be similar between the groups</p>
<p>Those categorized as lonely have higher levels of social isolation, higher symptom severity scores for all symptoms</p>